awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36794818-9F4673FE-CD3E-4A3D-9F0A-F036F3CBE483
Q36794818-9F4673FE-CD3E-4A3D-9F0A-F036F3CBE483
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36794818-9F4673FE-CD3E-4A3D-9F0A-F036F3CBE483
Active and passive immunotherapy: vaccines and antibodies.
P2860
Q36794818-9F4673FE-CD3E-4A3D-9F0A-F036F3CBE483
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36794818-9F4673FE-CD3E-4A3D-9F0A-F036F3CBE483
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0c2c7bdc9a5df9f41b14ad567757cf6e29cf2638
P2860
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.